FDA authorizes use of bivalent mRNA COVID-19 vaccines, monovalent rescinded
SILVER SPRING, MD, April 18, 2023—The U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered […]
The FDA authorizes Moderna and Pfizer COVID-19 boosters for all adults
SILVER SPRINGS, MD, November 19, 2021 – Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 […]
